HI
ARIA

HBK Investments’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

HBK Investments’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-947,249
Closed -$11.8M – 901
2016
Q4 		$11.8M Sell
947,249
-486,051
-34% -$5.85M 0.11% 136
2016
Q3 		$19.6M Sell
1,433,300
-62,000
-4% -$623K 0.18% 90
2016
Q2 		$11.1M Buy
1,495,300
+715,500
+92% +$5.37M 0.08% 145
2016
Q1 		$4.98M Sell
779,800
-53,651
-6% -$301K 0.05% 266
2015
Q4 		$5.21M Sell
833,451
-288,649
-26% -$1.89M 0.05% 210
2015
Q3 		$6.55M Buy
1,122,100
+1,001,400
+830% +$7.71M 0.07% 190
2015
Q2 		$998K Buy
+120,700
New +$1.07M 0.01% 563

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

HBK Investments's ARIA Position: Q1 2017 in Review

HBK Investments sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 947,249 shares — an estimated $11.8M sold.

HBK Investments first reported a position in ARIA in Q2 2015 and held it in 7 quarters. The position peaked at $19.6M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • HBK Investments reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • HBK Investments sold 947,249 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $11.8M.
  • HBK Investments first reported a position in Ariad Pharmaceuticals Inc in Q2 2015 and held it in 7 quarters.
  • HBK Investments's Ariad Pharmaceuticals Inc position peaked at $19.6M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on HBK Investments's 13F filing for Q1 2017, filed 15 May 2017.